Keywords: argatroban, acute, myocardial, infarction, results, argami-2, trial

Argatroban In Acute Myocardial Infarction

Article | 08 April 1998

Print This

The results of the ARGAMI-2 trial of Texas Biotechnology Corp's newanticoagulant Novastan (argatroban) have found that it is no better ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in